Holen Sie sich die Stockscreener-App
5.705
7.42%
0.385
Puma Biotechnology Inc Aktie (PBYI) Neueste Nachrichten
Additional Considerations Required While Assessing Puma Biotechnology's (NASDAQ:PBYI) Strong Earnings - Yahoo Finance
Barclays Maintains a Sell Rating on Puma Biotechnology (PBYI) With a $2 PT - MSN
Published on: 2025-08-15 07:16:55 - sundaytimes.kr
Puma Biotechnology Inc. Matches Institutional Buying FilterAnalyst Upgrade & Weekly Watchlist for Consistent Profits - beatles.ru
Should Value Investors Buy Puma Biotechnology (PBYI) Stock? - Yahoo Finance
Puma Biotechnology, Inc. (PBYI) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Puma Biotechnology, Inc. (NASDAQ:PBYI) Stock Catapults 43% Though Its Price And Business Still Lag The Market - simplywall.st
Puma Biotechnology shares rise 7.22% premarket as healthcare sector earnings grow 15.4%. - AInvest
Puma Biotechnology shares get favourable price bump on strong Q2 results - Mugglehead Magazine
Puma Biotechnology Grants Inducement Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4) - AInvest
Puma Biotechnology Surges 35%: What's Fueling This Biotech Breakout? - AInvest
10 Most Undervalued Biotech Stocks to Buy Now - Insider Monkey
Why is Puma Biotechnology Inc. stock going downStock Picks with Accelerated Return - kangso.co.kr
Puma Biotechnology Q2 Earnings Surprise: Revenue Down 9.3%, EPS Down 54% - AInvest
Results: Puma Biotechnology, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance
PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues - MSN
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q2 2025 Earnings Call Transcript - Insider Monkey
Puma Biotechnology 2025 Q2 Earnings Profitability Returns with 229.3% Net Income Surge - AInvest
Puma Biotechnology's Q2 Earnings Outperformance and Nerlynx Momentum Signal a Strategic Buy Opportunity - AInvest
Puma Biotechnology Awards Nearly 28,000 Shares to Three New Employees Under Nasdaq Rule - Stock Titan
Puma Biotechnology Q2 2025 slides: NERLYNX revenue grows 14% quarter-over-quarter - Investing.com India
Earnings call transcript: Puma Biotechnology beats Q2 2025 earnings forecast By Investing.com - Investing.com Nigeria
Earnings call transcript: Puma Biotechnology beats Q2 2025 earnings forecast - Investing.com
Puma Biotechnology Flips To Profit On Cancer Drug Sales - Finimize
Puma Biotechnology Inc (PBYI) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Puma Biotech: Q2 Earnings Snapshot - Connecticut Post
Puma Biotechnology 2025 Q2 Earnings Strong Performance as Net Income Surges 229.3% - AInvest
Puma anticipates $192M–$198M NERLYNX revenue for 2025 as company advances alisertib trials - MSN
Puma Biotechnology Reports Second Quarter 2025 Financial Results - BioSpace
Puma (PBYI) Q2 Revenue Rises 11% - AOL.com
Puma Biotechnology Reports Strong Q2 2025 Results - TipRanks
Puma Biotechnology Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Puma Biotechnology: Hold Rating Amid Stable Q2 Performance and Uncertain Trial Outcomes - TipRanks
Puma Biotechnology Anticipates $192M-$198M NERLYNX Revenue for 2025 Amid Alisertib Trials Advancement - AInvest
Puma Biotechnology's Q2 2025: Key Contradictions in Alisertib Strategy, In-Licensing, and Sales Growth - AInvest
Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance
Puma Biotechnology files Form 8-K regarding Q2 2025 results - Stock Titan
Puma Biotechnology Reports Second Quarter Financial Results - Yahoo Finance
Screener Results Flag Puma Biotechnology Inc. as OversoldGrowth Based Investment Plan Guidance Highlighted - metal.it
What are the latest earnings results for Puma Biotechnology Inc.Get professional advice for portfolio optimization - Jammu Links News
How volatile is Puma Biotechnology Inc. stock compared to the marketInvest in high-yield stocks with confidence - Jammu Links News
What drives Puma Biotechnology Inc. stock priceDiscover high-impact stocks for growth - Jammu Links News
How strong is Puma Biotechnology Inc. company’s balance sheetAchieve consistent profits with proven methods - Jammu Links News
What are analysts’ price targets for Puma Biotechnology Inc. in the next 12 monthsFree Market Volatility Navigation Tips - Jammu Links News
What makes Puma Biotechnology Inc. stock price move sharplyOutstanding capital growth - Jammu Links News
What catalysts could drive Puma Biotechnology Inc. stock higher in 2025Tremendous wealth creation - Jammu Links News
Is Puma Biotechnology Inc. a good long term investmentStay ahead with daily market updates - Jammu Links News
What analysts say about Puma Biotechnology Inc. stockInvest confidently with professional market insights - Jammu Links News
What are Puma Biotechnology Inc. company’s key revenue driversUnlock powerful portfolio optimization tools - Jammu Links News
What is the dividend policy of Puma Biotechnology Inc. stockRobust financial gains - Jammu Links News
Is Puma Biotechnology Inc. stock overvalued or undervaluedDiscover market opportunities with expert help - Jammu Links News
Puma Biotechnology (NASDAQ:PBYI) shareholders have endured a 70% loss from investing in the stock five years ago - Yahoo Finance
0.07%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):